Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study

BACKGROUND: Inhaled corticosteroid/long-acting β(2)-agonist combinations (ICS/LABA) have emerged as first line therapies for chronic obstructive pulmonary disease (COPD) patients with exacerbation history. No randomized clinical trial has compared exacerbation rates among COPD patients receiving bud...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Respir Res
Prif Awduron: Kern, David M, Davis, Jill, Williams, Setareh A, Tunceli, Ozgur, Wu, Bingcao, Hollis, Sally, Strange, Charlie, Trudo, Frank
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2015
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409772/
https://ncbi.nlm.nih.gov/pubmed/25899176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0210-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg